In-vitro Toxicology Testing Market To Witness Huge Potential In The Future

In-vitro Toxicology Testing Market Summary

The global in-vitro toxicology testing market size was estimated at USD 31,029.0 million in 2023 and is projected to reach USD 64,815.2 million by 2030, growing at a CAGR of 11.1% from 2024 to 2030. The growth of the market is attributed to continuous developments in toxicology research and advancement of technologies, which are enabling faster, safer, and more ethical testing processes for evaluating chemical and drug safety.

In addition, rising emphasis on development of personalized medicines is further expected to boost the market during the forecast period. Personalized treatment requires accurate toxicity profiling tailored to individual patient groups, which increases the demand for advanced in-vitro assays capable of predicting human-specific responses. Awareness regarding the limitations and challenges associated with traditional toxicology screening methods has been growing, especially regarding high costs, lengthy timelines, and ethical concerns related to animal testing. This has led to a broader acceptance of in-vitro testing as a valuable tool for assessing the safety and efficacy of pharmaceutical compounds, industrial chemicals, cosmetics, and food additives.

Key Market Trends & Insights

• North America dominated the market and accounted for a 47.73% share in 2023 due to advanced healthcare infrastructure, strong regulatory support, and high investment in R&D activities.
• By method, the cellular assay accounted for the largest share in terms of revenue and is expected to grow over the forecasted period, driven by its ability to replicate cellular behavior and generate reliable toxicity results.
• By product, the consumables segment dominated the market in 2023 and is estimated to grow at the fastest CAGR over the forecast period because of frequent usage and continuous need for replenishment in research and testing laboratories.
• By end use, the pharmaceutical industry end-use segment held a major share in the market in 2023 due to increasing drug development activities and the rising need to ensure safety during early-stage screening.

Order a free sample PDF of the In-vitro Toxicology Testing Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 31,029.0 Million
• 2030 Projected Market Size: USD 64,815.2 Million
• CAGR (2024-2030): 11.1%
• North America: Largest market in 2023

Key Companies & Market Share Insights

Some of the key players operating in the market include Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, Eurofins Scientific, and Abbott Laboratories. These companies focus on expanding their service portfolios, enhancing technological capabilities, and strategic collaborations to strengthen their market presence. With increasing demand for reliable and cost-effective testing solutions, these companies are actively engaged in innovative research and development to address emerging challenges in toxicology testing.

Emerging players in the in-vitro toxicology testing market, like InSphero and MatTek Corporation, are leveraging cutting-edge technologies and forming strategic partnerships to gain a foothold. Their activities include developing advanced 3D cell culture models and organ-on-a-chip platforms. These companies aim to disrupt the market by offering innovative and more predictive in-vitro toxicology solutions, catering to the growing demand for alternatives to traditional animal testing methods.

Key Players

• Charles River Laboratories International, Inc.
• SGS S.A.
• Merck KGaA
• Eurofins Scientific
• Abbott Laboratories
• Laboratory Corporation of America Holdings
• Evotec S.E.
• Thermo Fisher Scientific, Inc.
• Quest Diagnostics Incorporated
• Agilent Technologies, Inc.
• Catalent, Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• BioIVT
• Gentronix

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The in-vitro toxicology testing market is poised for strong growth as industries continue shifting toward non-animal models that provide faster, more accurate, and ethically responsible toxicity insights. Increasing regulatory approval for alternative test methods, coupled with rising research investments in biotechnology and personalized treatments, will significantly enhance market adoption. Advancements in 3D cell culture, organ-on-chip systems, and computational toxicology are expected to further improve predictability and reduce development costs for new therapies. With expanding outsourcing trends and the ongoing need for reliable safety assessment across pharmaceuticals, cosmetics, and chemicals, the market is positioned for sustained expansion through 2030.